6 recalls tagged with “lithium battery”.
Rising Pharmaceuticals recalls 1,200 Temozolomide 5 mg capsules nationwide after a stability test found out-of-spec impurities. The drug is Rx-only, with NDC 16571-816-51 and lot 1TM0524003A. Stop using immediately and contact a healthcare provider for guidance.
Nilotinib capsules manufactured for Cipla USA are recalled nationwide after stability testing showed out-of-spec results. The failure involves description and appearance by visual inspection at six months of long-term stability. Patients and healthcare providers should stop using the product immediately and contact Cipla USA for guidance.
Teva Pharmaceuticals recalled 7,448 bottles of Metoprolol Succinate Extended-Release Tablets nationwide after failed dissolution specifications were identified. The recall involves 100 mg, 100‑tablet bottles (NDC 45963-677-11) and 1,000‑tablet bottles (NDC 45963-677-96). The defect may affect drug release and efficacy. Patients should stop using affected bottles and contact Teva or their clinician
Datascope recalled 10,897 CS100 IABP devices worldwide on Jan. 23, 2026. The issue concerns battery runtime and cycle specifications in the device Instructions for Use. Healthcare providers and patients must stop using the device and follow recall instructions.
Gold Star Distribution Inc. is recalling Carmex lip balm in 12-count jars and 12-count tubes distributed nationwide in the United States. The recall cites CGMP deviations and insanitary conditions at the distribution center, including rodent exposure. Consumers and healthcare providers should stop using the product immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution is recalling Liquid DayQuil 12/8oz distributed nationwide in the United States. The recall cites CGMP deviations and insanitary conditions, including rodent exposure at the distribution center. Consumers and healthcare providers should stop using the product immediately and contact Gold Star Distribution for guidance.